SV40-mediated oncogenesis

Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies

Volumn , Issue , 2005, Pages 34-59

  Bocchetta, Maurizio ^a   Carbone, Michele ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248510885     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-28274-2_3     Document Type: Chapter

References (146)

1. Sweet BH, Hilleman MR. The vacuolating virus, S. V.40. Proc Soc Exp Biol Med 1960;105:420-427.
2. Eddy BE. Tumors produced in hamsters by SV40. Fed Proc 1962;21:930-935.
3. Eddy BE, Borman GS, Grubbs GE, Young RD. Identification of the oncogenic substance in Rhesus monkey kidney cell cultures as simian virus 40. Virology 1962;17:65-75.
4. Fisher SG, Weber L, Carbone M. Cancer risk associated with simian virus 40 contaminated polio vaccine. Anticancer Res 1999;19:2173-2180.
5. Heinonen OP, Shapiro S, Monson RR, Harts SC, Rosenberg L, Slone D. Immunization during pregnancy against poliomyelitis and influenza in relationship to childhood malignancy. Int J Epidemiol 1973;2:229-235.
6. Innis MD. Oncogenesis and poliomyelitis vaccine. Nature 1968;219:972-973.
7. Mortimer EA Jr, Lepow ML, Gold E, Robbins FC, Burton GJ, Fraumeni JF Jr. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N Engl J Med 1981;305:1517-1518.
8. Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF Jr, Goedert JJ. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 1998;279:292-295.
9. Krieg P, Amtmann E, Jonas D, Fischer H, Zang K, Sauer G. Episomal simian virus 40 genomes in human brain tumors. Proc Natl Acad Sci USA 1981;78:6446-6450.
10. Krieg P, Scherer G. Cloning of SV40 genomes from human brain tumors. Virology 1984;138:336-340.
11. Meinke W, Goldstein DA, Smith RA. Simian virus 40-related DNA sequences in a human brain tumor. Neurology 1979;29:1590-1594.
12. Scherneck S, Rudolph M, Geissler E, et al. Isolation of a SV40-like papovavirus from a human glioblastoma. Int J Cancer 1979;24:523-531.
13. Soriano F, Shelburne CE, Gokcen M. Simian virus 40 in a human cancer. Nature 1974;249:421-424.
14. Tabuchi K, Kirsch WM, Low M, Gaskin D, Van Buskirk J, Maa S. Screening of human brain tumors for SV40-related T antigen. Int J Cancer 1978;21:12-17.
15. Weiss AF, Portmann R, Fischer H, Simon J, Zang KD. Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc Natl Acad Sci USA 1975;72:609-613.
16. Gazdar AF, Butel JS, Carbone M. Opinion: SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2002;2:957-964.
17. Jasani B, Cristaudo A, Emri SA, et al. Association of SV40 with human tumours. Semin Cancer Biol 2001;11:49-61.
18. Klein G, Powers A, Croce C. Association of SV40 with human tumors. Oncogene 2002;21:1141-1149.
19. Wong M, Pagano JS, Shiller JT, Tevethia SS, Raab-Traub N, Gruber J. New associations of human papillomavirus, simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst 2002;94:267-273.
20. Stratton K, Almario DA, McCormick M, eds. IOM report: immunization safety review. SV40 contamination of poliovaccine and cancer. National Academy of Sciences, www.nap. edu, 2002.
21. Bocchetta M, Di Resta I, Powers A, et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci USA 2000;97:10214-10219.
22. Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 1999;91:119-134.
23. Carbone M, Rizzo P, Procopio A, et al. SV40-like sequences in human bone tumors. Oncogene 1996;13:527-535.
24. Atwood WJ, Norkin LC. Class I major histocompatibility proteins as cell surface receptors for simian virus 40. J Virol 1989;63:4474-4477.
25. Breau WC, Atwood WJ, Norkin LC. Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J Virol 1992;66:2037-2045.
26. Anderson HA, Chen Y, Norkin LC. MHC class I molecules are enriched in caveolae but do not enter with simian virus 40. J Gen Virol 1998;79:1469-1477.
27. Nakanishi A, Shum D, Morioka H, Otsuka E, Kasamatsu H. Interaction of the Vp3 nuclear localization signal with the importin alpha 2/beta heterodimer directs nuclear entry of infecting simian virus 40. J Virol 2002;76:9368-9377.
28. Berk AJ, Sharp PA. Spliced early mRNAs of simian virus 40. Proc Natl Acad Sci USA 1978;75:1274-1278.
29. Cole CN. Polyomavirinae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields' Virology, 3rd ed. Philadelphia: Lippincott-Raven, 1996.
30. Noble JC, Prives C, Manley JL. In vitro splicing of simian virus 40 early pre mRNA. Nucleic Acids Res 1986;14:1219-1235.
31. Mastrangelo IA, Hough PV, Wall JS, Dodson M, Dean FB, Hurwitz J. ATPdependent assembly of double hexamers of SV40 T antigen at the viral origin of DNA replication. Nature 1989;338:658-662.
32. Collins KL, Kelly TJ. Effects of T antigen and replication protein A on the initiation of DNA synthesis by DNA polymerase alpha-primase. Mol Cell Biol 1991;11:2108-2115.
33. Dean FB, Bullock P, Murakami Y, Wobbe CR, Weissbach L, Hurwitz J. Simian virus 40 (SV40) DNA replication: SV40 large T antigen unwinds DNA containing the SV40 origin of replication. Proc Natl Acad Sci USA 1987;84:16-20.
34. Wiley SR, Kraus RJ, Zuo F, Murray EE, Loritz K, Mertz JE. SV40 earlytolate switch involves titration of cellular transcriptional repressors. Genes Dev 1993;7:2206-2219.
35. Zuo F, Mertz JE. Simian virus 40 late gene expression is regulated by members of the steroid/thyroid hormone receptor superfamily. Proc Natl Acad Sci USA 1995;92:8586-8590.
36. Keller JM, Alwine JC. Analysis of an activatable promoter: sequences in the simian virus 40 late promoter required for T-antigen-mediated transactivation. Mol Cell Biol 1985;5:1859-1869.
37. Dean DA, Li PP, Lee LM, Kasamatsu H. Essential role of the Vp2 and Vp3 DNA-binding domain in simian virus 40 morphogenesis. J Virol 1995;69:1115-1121.
38. Gordon-Shaag A, Ben-Nun-Shaul O, Roitman V, Yosef Y, Oppenheim A. Cellular transcription factor Sp1 recruits simian virus 40 capsid proteins to the viral packaging signal, ses. J Virol 2002;76:5915-5924.
39. Gordon-Shaag A, Ben-Nun-Shaul O, Kasamatsu H, Oppenheim AB, Oppenheim A. The SV40 capsid protein VP3 cooperates with the cellular transcription factor Sp1 in DNA-binding and in regulating viral promoter activity. J Mol Biol 1998;275:187-195.
40. Carswell S, Alwine JC. Simian virus 40 agnoprotein facilitates perinuclearnuclear localization of VP1, the major capsid protein. J Virol 1986;60:1055-1061.
41. Darbinyan A, Darbinian N, Safak M, Radhakrishnan S, Giordano A, Khalili K. Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene 2002;21:5574-5581.
42. Safak M, Khalili K. Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription. J Neurovirol 7:288-292.
43. Sack GH Jr. Human cell transformation by simian virus 40-a review. In Vitro 1980;17:1-19.
44. Meyer HM Jr, Hopps HE, Rogers NG, et al. Studies on simian virus 40. J Immunol 1962;88:796-806.
45. Wobbe CR, Weissbach L, Borowiec JA, et al. Replication of simian virus 40 origin-containing DNA in vitro with purified proteins. Proc Natl Acad Sci USA 1987;84:1834-1838.
46. Shay JW, Van der Haegen BA, Ying Y, Wright WE. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 1993;209:45-52.
47. Brinster RL, Chen HY, Messing A, van Dyke T, Levine AJ, Palmiter RD. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 1984;37:367-379.
48. Ewald D, Li M, Efrat S, et al. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 1996;273:1384-1386.
49. Maroulakou IG, Anver M, Garrett L, Green JE. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3 (1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci USA 1997;91:11236-11240.
50. Tzeng YJ, Guhl E, Graessmann M, Graessmann A. Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene. Oncogene 1993;8:1965-1971.
51. Clayson ET, Brando LV, Compans RW. Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis. J Virol 1989;63:2278-2288.
52. O'Neill FJ, Carroll D. Amplification of papovavirus defectives during serial low multiplicity infections. Virology 1981;112:800-803.
53. O'Neill FJ, Carney H, Hu Y. Host range analysis of simian virus 40, BK virus and chimaeric SV40/BKV: relative expression of large T-antigen and Vp1 in infected and transformed cells. Dev Biol Stand 1998;94:191-205.
54. Shein HM. Transformation of astrocytes and destruction of spongioblasts induced by a simian tumor virus (SV40) in cultures of human fetal neuroglia. J Neuropathol Exp Neurol 1967;26:60-76.
55. Stein HM, Enders JF. Multiplication of cytopathogenicity of simian vascuolating virus 40 in cultures of human tissues. Proc Soc Exp Biol Med 1962;109:495-500.
56. O'Neill FJ, Xu XL, Miller TH. Host range determinant in the late region of SV40 and RF virus affecting growth in human cells. Intervirology 1990;31:175-187.
57. Aaronson SA. Susceptibility of human cell strains to transformation by simian virus 40 and simian virus 40 deoxyribonucleic acid. J Virol 1970;6:470-475.
58. Carp RI, Gilden RV. Acomparison of the replication cycles of simian virus 40 in human diploid and African green monkey kidney cells. Virology 1966;28:150-162.
59. Bryan TM, Reddel RR. SV40-induced immortalization of human cells. Crit Rev Oncol 1994;5:331-357.
60. Staufenbiel M, Deppert W. Different structural systems of the nucleus are targets for SV40 large T antigen. Cell 1983;33:173-181.
61. Hansen R, Reddel R, Braithwaite A. The transforming oncoproteins determine the mechanism by which p53 suppresses cell transformation: pRbmediated growth arrest or apoptosis. Oncogene 1995;11:2535-2545.
62. Testa JR, Giordano A. SV40 and cell cycle perturbations in malignant mesothelioma. Semin Cancer Biol 2001;11:31-38.
63. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992;89:7491-7495.
64. Lomazzi M, Moroni MC, Jensen MR, Frittoli E, Helin K. Suppression of the p53-or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry. Nat Genet 2002;31:190-194.
65. Wang B, Matsuoka S, Carpenter PB, Elledge SJ. 53BP1, a mediator of the DNA damage checkpoint. Science 2002;298:1435-1438.
66. Avantaggiati ML, Carbone M, Graessmann A, Nakatani Y, Howard B, Levine AS. The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J 1996;15:2236-2248.
67. Lill NL, Tevethia MJ, Eckner R, Livingston DM, Modjtahedi N. p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen. J Virol 1997;71:129-137.
68. Ali SH, DeCaprio JA. Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin Cancer Biol 2001;11:15-23.
69. Miccoli L, Biard DS, Creminon C, Angulo JF. Human kin17 protein directly interacts with the simian virus 40 large T antigen and inhibits DNA replication. Cancer Res 2002;62:5425-5435.
70. Damania B, Alwine JC. TAF-like function of SV40 large T antigen. Genes Dev 1996;10:1369-1381.
71. Adamczewski JP, Gannon JV, Hunt T. Simian virus 40 large T antigen associates with cyclin A and p33cdk2. J Virol 1993;67:6551-6557.
72. Baserga R, Sell C, Porcu P, Rubini M. The role of the IGF-I receptor in the growth and transformation of mammalian cells. Cell Prolif 1994;27:63-71.
73. Porcu P, Grana X, Li S, Swantek J, De Luca A, Giordano A, Baserga R. An E2F binding sequence negatively regulates the response of the insulinlike growth factor 1 (IGF-I) promoter to simian virus 40T antigen and to serum. Oncogene 1994;9:2125-2134.
74. Oshima J, Steinmann KE, Campisi J, Schlegel R. Modulation of cell growth, p34cdc2 and cyclin A levels by SV-40 large T antigen. Oncogene 1993;8:2987-2993.
75. Chen H, Campisi J, Padmanabhan R. SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor. J Biol Chem 1996;271:13959-13967.
76. Mekeel KL, Tang W, Kachnic LA, Luo CM, DeFrank JS, Powell SN. Inactivation of p53 results in high rates of homologous recombination. Oncogene 1997;14:1847-1857.
77. Ray FA, Meyne J, Kraemer PM. SV40 T antigen induced chromosomal changes reflect a process that is both clastogenic and aneuploidogenic and is ongoing throughout neoplastic progression of human fibroblasts. Mutat Res 1992;284:265-273.
78. Cacciotti P, Libener R, Betta P, et al. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci USA 2001;98:12032-12037.
79. Foddis R, De Rienzo A, Broccoli D, et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002;21:1434-1442.
80. Toyooka S, Carbone M, Toyooka KO, et al. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. Oncogene 2002;21:4340-4344.
81. Bocchetta M, Miele L, Pass HI, Carbone M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene 2002;22:81-89.
82. Sullivan CS, Pipas JM. T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev 2002;66:179-202.
83. Wang JK, Knudsen ES, Welch PJ. The retinoblastoma tumor suppressor protein. Adv Cancer Res 1994;64:25-85.
84. Kim HY, Ahn BY, Cho Y. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J 2001;20:295-304.
85. Mungre S, Enderle K, Turk B, et al. Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation. J Virol 1994;68:1675-1681.
86. Rundell K, Parakati R. The role of the SV40 ST antigen in cell growth promotion and transformation. Semin Cancer Biol 2001;11:5-13.
87. Frost JA, Alberts AS, Sontag E, Guan K, Mumby MC, Feramisco JR. Simian virus 40 small t antigen cooperates with mitogen-activated kinases to stimulate AP-1 activity. Mol Cell Biol 1994;14:6244-6252.
88. Watanabe G, Howe A, Lee RJ, et al. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc Natl Acad Sci USA 1996;93:12861-12866.
89. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol 1995;69:2491-2500.
90. Qin XQ, Livingston DM, Kaelin WG Jr, Adams PD. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 1994;91:10918-10922.
91. Cole SL, Tevethia MJ. Simian virus 40 large T antigen and two independent T-antigen segments sensitize cells to apoptosis following genotoxic damage. J Virol 2002;76:8420-8432.
92. Conzen SD, Snay CA, Cole CN. Identification of a novel antiapoptotic functional domain in simian virus 40 large T antigen. J Virol 1997;71:4536-4543.
93. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-776.
94. Shelly LL, Fuchs C, Miele L. Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds. J Cell Biochem 1999;73:164-175.
95. Rouquet N, Allemand I, Molina T, Bennoun M, Briand P, Joulin V. Fasdependent apoptosis is impaired by SV40 T-antigen in transgenic liver. Oncogene 1995;11:1061-1067.
96. Gillet R, Cavard C, Grimber G, Briand P, Joulin V. Hepatic expression of SV40 small-T antigen blocks the in vivo CD95-mediated apoptosis. Biochem Biophys Res Commun 2001;284:369-376.
97. Kolzau T, Hansen RS, Zahra D, Reddel RR, Braithwaite AW. Inhibition of SV40 large T antigen induced apoptosis by small T antigen. Oncogene 1999;18:5598-5603.
98. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nat Rev Cancer 2002;2:489-501.
99. Gjoerup O, Zaveri D, Roberts TM. Induction of p53-independent apoptosis by simian virus 40 small t antigen. J Virol 2001;75:9142-9155.
100. Evan G, Littlewood T. A matter of life and cell death. Science 1998;281:1317-1322.
101. Prisco M, Santini F, Baffa R, et al. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor. J Biol Chem 2002;277:32078-32085.
102. Macera-Bloch L, Houghton J, Lenahan M, Jha KK, Ozer HL. Termination of lifespan of SV40-transformed human fibroblasts in crisis is due to apoptosis. J Cell Physiol 2002;190:332-344.
103. Huschtscha LI, Holliday R. Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts. J Cell Sci 1983;63:77-99.
104. Ozer HL, Banga SS, Dasgupta T, et al. SV40-mediated immortalization of human fibroblasts. Exp Gerontol 1996;31:303-310.
105. Weinberg RA. Telomeres. Bumps on the road to immortality. Nature 1998;396:23-24.
106. Stewart SA, Hahn WC, O'Connor BF, et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 2002;99:12606-12611.
107. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997;3:1271-1274.
108. Bartek J, Bartkova J, Kyprianou N, et al. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci USA 1991;88:3520-3524.
109. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999;400:464-468.
110. Hahn WC, Dessain SK, Brooks MW, et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002;22:2111-2123.
111. Weijzen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002;8:979-986.
112. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol 1993;142:1524-1533.
113. De Rienzo A, Tor M, Sterman DH, Aksoy F, Albelda SM, Testa JR. Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. J Cell Biochem 2002;84:455-449.
114. Emri S, Kocagoz T, Olut A, Gungen Y, Mutti L, Baris YI. Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Res 2000;20:891-894.
115. Heinsohn S, Scholz RB, Weber B, et al. SV40 sequences in human osteosarcoma of German origin. Anticancer Res 2000;20:4539-4545.
116. Hirvonen A, Mattson K, Karjalainen A, et al. Simian virus 40 (SV40) - like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol Carcinog 1999;26:93-99.
117. Leithner A, Weinhaeusel A, Windhager R, et al. Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas. Cancer Biol Ther 2002;1:375-379.
118. Priftakis P, Bogdanovic G, Hjerpe A, Dalianis T. Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas. Anticancer Res 2002;22:1357-1360.
119. Carbone M, Pass HI, Rizzo P, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994;9:1781-1790.
120. Shivapurkar N, Wiethege T, Wistuba II, et al. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 1999;76:181-188.
121. Carbone M, Rizzo P, Grimley PM, et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 1997;3:908-912.
122. De Luca A, Baldi A, Esposito V, et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med 1997;3:913-916.
123. Waheed I, Guo ZS, Chen GA, Weiser TS, Nguyen DM, Schrump DS. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells. Cancer Res 1999;59:6068-6073.
124. Wiman KG, Klein G. An old acquaintance resurfaces in human mesothelioma. Nat Med 1997;3:839-840.
125. Ohshima K, Suzumiya J, Kanda M, Kato A, Kikuchi M. Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease. Cancer Lett 1998;122:43-50.
126. Ambinder RF. Gammaherpesviruses and "hit-and-run" oncogenesis. Am J Pathol 2000;156:1-3.
127. Inozemtseva LS, Manuilova ES, Marshak MI, Nikolaeva NP, Gnedoi SN, Grivennikov IA. Isolation and characterization of immortalized human fibroblasts. Mol Gen Mikrobiol Virusol 1997;3:27-33.
128. Nevels M, Tauber B, Spruss T, Wolf H, Dobner T. "Hit-and-run" transformation by adenovirus oncogenes. J Virol 2001;75:3089-3094.
129. Smith KT, Campq MS. "Hit and run" transformation of mouse C127 cells by bovine papillomavirus type 4: the viral DNA is required for the initiation but not for maintenance of the transformed phenotype. Virology 1988;164:39-47.
130. Tzeng YJ, Zimmermann C, Guhl E, Berg B, Avantaggiati ML, Graessmann A. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors. Oncogene 1998;16:2103-2114.
131. Sepulveda AR, Finegold MJ, Smith B, et al. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene. Cancer Res 1989;49:6108-6117.
132. Rizzo P, Bocchetta M, Powers A, et al. SV40 and the pathogenesis of mesothelioma. Semin Cancer Biol 2001;11:63-71.
133. Jang MS, Zlobin A, Kast WM, Miele L. Notch signaling as a target in multimodality cancer therapy. Curr Opin Mol Ther 2000;2:55-65.
134. Padgett BL, Walker DL. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 1973;127:467-470.
135. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973;128:784-787.
136. Del Valle L, Gordon J, Enam S, et al. Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer 2002;94:267-273.
137. Enam S, Del Valle L, Lara C, et al. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res 2002;62:7093-7101.
138. Imperiale MJ. The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer. Virology 2000;267:1-7.
139. Krynska B, Del Valle L, Croul S, et al. Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci USA 1999;96:11519-11524.
140. Houff SA, London WT, DiChiro G, et al. Neuroradiological studies of JCVinduced astrocytomas in nonhuman primates. Prog Clin Biol Res 1983;105:253-259.
141. Corallini A, Altavilla G, Cecchetti MG, et al. Ependymomas, malignant tumors of pancreatic islets, and osteosarcomas induced in hamsters by BK virus, a human papovavirus. J Natl Cancer Inst 1978;61:875-883.
142. Noss G, Stauch G, Mehraein P, Georgii A. Oncogenic activity of the BK type of human papova virus in newborn Wistar rats. Arch Virol 1981;69:239-251.
143. Shah KV. Evidence for an SV40-related papovavirus infection of man. Am J Epidemiol 1972;95:199-206.
144. Vastag B. Sewage yields clues to SV40 transmission. JAMA 2002;288:1337-1338.
145. Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol 2002;29:2-17.
146. Stewart SA, Weinberg RA. Senescence: does it all happen at the ends? Oncogene 2002;21:627-630.